Skip to main content
Fig. 3 | Experimental Hematology & Oncology

Fig. 3

From: Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant

Fig. 3

A scoring system using disease status before second HCT and remission duration after first HCT can predict survival outcome after second HCT. Disease status before second HCT (0: CR vs. 1: non-CR) and remission duration after first HCT (0: > 12 months; 1: 6 to 12 months; 2: < 6 months) could be used to predict the outcomes after second HCT. The outcomes of the patients with a score < 2 were significant better than those who ≥ 2, which selected out the patients who could benefit most from second HCT

Back to article page

Experimental Hematology & Oncology

ISSN: 2162-3619

Contact us